Tauroursodeoxycholic acid D4
| Product Name | Tauroursodeoxycholic acid D4 |
|---|---|
| Alternate Names | Ursodeoxycholic Stable Isotopes, Stable Isotopes of Ursodeoxycholic |
| CAT No. | CS-O-02935 |
| CAS No. | 14605-22-2 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 503.73 g/mol |
| Mol. For. | C₂₆H₄₁D₄NO₆S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ursodeoxycholic |
| Purity | Not less than 90 % |
| Smileys | C[C@]1([C@]([H])([C@]2([H])[C@@H](O)C[C@@]3(C([2H])([C@@H](C([2H])(C[C@]3(C)[C@]2(CC1)[H])[2H])O)[2H])[H])CC4)[C@]4([C@@H](CCC(NCCS(=O)(O)=O)=O)C)[H] |
| Canonical Smiles | CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C |
| InchIKey | BHTRKEVKTKCXOH-LBSADWJPSA-N |
| Inchl | InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1 |
| IUPAC | 2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Tauroursodeoxycholic acid D4 (TUDCA-D4) is a deuterated form of Tauroursodeoxycholic acid (TUDCA), which is a bile acid found in the human body. TUDCA-D4 is a potent and selective inhibitor of apoptosis, which is the process of programmed cell death. It has been shown to have a variety of potential therapeutic applications, including treatment of liver disease, neurodegenerative disorders, and various forms of cancer.
TUDCA-D4 works by inhibiting the release of certain pro-apoptotic factors, such as cytochrome c and caspase-9, which are involved in the initiation of the apoptosis cascade. By inhibiting apoptosis, TUDCA-D4 can help to protect cells from a variety of damaging stimuli, including oxidative stress, inflammation, and exposure to toxic substances.
In addition to its anti-apoptotic effects, TUDCA-D4 is also known to have a number of other beneficial effects on cellular metabolism and function. It has been shown to help regulate glucose and lipid metabolism, reduce inflammation, and improve mitochondrial function.
From a chemical standpoint, TUDCA-D4 is a deuterated form of TUDCA, which means that it contains a higher percentage of deuterium atoms than its natural counterpart. Deuterium is a stable isotope of hydrogen, and its presence can alter the physical and chemical properties of a molecule in a number of ways. In the case of TUDCA-D4, the increased stability conferred by the deuterium atoms may contribute to its enhanced anti-apoptotic effects and improved pharmacokinetic profile.
Get an Instant Quote
Related Compounds
Ursodeoxycholic Acid D5 Methyl Ester | Ursodeoxycholic Acid D5 | Tauroursodeoxycholic-D5 Acid | Ursodeoxycholic Acid D4 | Glycoursodeoxycholic acid D4 | Glycoursodeoxycholic Acid D5 |